Status:
COMPLETED
Study to Investigate the Effects Single Oral Dose of AZD1386 (Capsaicin)
Lead Sponsor:
AstraZeneca
Conditions:
Capsaicin Evoked Pain
Heat Sensitivity
Eligibility:
All Genders
20-45 years
Phase:
PHASE1
Brief Summary
A double-blind, randomized, single-centre, placebo-controlled, crossover study to investigate the effects of a single oral dose of AZD1386 on intradermal capsaicin evoked pain symptoms and heat sensit...
Eligibility Criteria
Inclusion
- Clinical normal physical findings, including BP, pulse rate \>45 bpm, ECG and laboratory assessments
- Body Mass Index (BMI) of ≥18 to ≤30 kg/m2 and weight of ≥50 to ≤100 kg.
- Non-fertile females
Exclusion
- History of hypersensitivity, allergy or atopic/skin disease as judged by Investigator.
- History of somatic or psychiatric disease/condition, which may interfere with the objectives of the study as judged by the Investigator.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00692146
Start Date
January 1 2008
End Date
May 1 2008
Last Update
June 6 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.